Identification and Characterization of vB_PreP_EPr2, a Lytic Bacteriophage of Pan-Drug Resistant Providencia rettgeri .
Jaime L MenckeYunxiu HeAndrey A FilippovMikeljon P NikolichAshton T BelewDerrick E FoutsPatrick T Mc GannBrett E SwierczewskiDerese GetnetDamon W EllisonKatie R MargulieuxPublished in: Viruses (2022)
Providencia rettgeri is an emerging opportunistic Gram-negative pathogen with reports of increasing antibiotic resistance. Pan-drug resistant (PDR) P. rettgeri infections are a growing concern, demonstrating a need for the development of alternative treatment options which is fueling a renewed interest in bacteriophage (phage) therapy. Here, we identify and characterize phage vB_PreP_EPr2 (EPr2) with lytic activity against PDR P. rettgeri MRSN 845308, a clinical isolate that carries multiple antibiotic resistance genes. EPr2 was isolated from an environmental water sample and belongs to the family Autographiviridae , subfamily Studiervirinae and genus Kayfunavirus , with a genome size of 41,261 base pairs. Additional phenotypic characterization showed an optimal MOI of 1 and a burst size of 12.3 ± 3.4 PFU per bacterium. EPr2 was determined to have a narrow host range against a panel of clinical P. rettgeri strains. Despite this fact, EPr2 is a promising lytic phage with potential for use as an alternative therapeutic for treatment of PDR P. rettgeri infections.
Keyphrases
- drug resistant
- multidrug resistant
- gram negative
- acinetobacter baumannii
- antibiotic resistance genes
- pseudomonas aeruginosa
- microbial community
- cystic fibrosis
- bone marrow
- emergency department
- climate change
- genome wide
- mesenchymal stem cells
- anaerobic digestion
- smoking cessation
- cell therapy
- adverse drug
- genome wide identification
- drug induced